News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,592 Results
Type
Article (57952)
Company Profile (100)
Press Release (642540)
Multimedia
Podcasts (71)
Webinars (13)
Section
Business (194886)
Career Advice (2918)
Deals (35324)
Drug Delivery (112)
Drug Development (80617)
Employer Resources (166)
FDA (15828)
Job Trends (14793)
News (335681)
Policy (32333)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Standard (1)
2026 Bio NC Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2669)
Academic (2)
Accelerated approval (6)
Adcomms (23)
Allergies (87)
Alliances (47232)
ALS (92)
Alzheimer's disease (1318)
Antibody-drug conjugate (ADC) (121)
Approvals (15827)
Artificial intelligence (259)
Autoimmune disease (24)
Automation (16)
Bankruptcy (329)
Best Places to Work (11429)
BIOSECURE Act (19)
Biosimilars (104)
Biotechnology (69)
Bladder cancer (68)
Brain cancer (27)
Breast cancer (274)
Cancer (2155)
Cardiovascular disease (168)
Career advice (2464)
Career pathing (33)
CAR-T (149)
Cell therapy (425)
Cervical cancer (20)
Clinical research (65442)
Collaboration (805)
Compensation (390)
Complete response letters (24)
COVID-19 (2565)
CRISPR (43)
C-suite (250)
Cystic fibrosis (103)
Data (2082)
Decentralized trials (2)
Denatured (26)
Depression (44)
Diabetes (258)
Diagnostics (6565)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (42)
Drug discovery (121)
Drug pricing (106)
Drug shortages (27)
Duchenne muscular dystrophy (88)
Earnings (75126)
Editorial (42)
Employer branding (21)
Employer resources (145)
Events (108280)
Executive appointments (745)
FDA (17047)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (755)
Gene editing (109)
Generative AI (20)
Gene therapy (293)
GLP-1 (715)
Government (4670)
Grass and pollen (6)
Guidances (49)
Healthcare (19237)
Huntington's disease (20)
IgA nephropathy (23)
Immunology and inflammation (121)
Indications (28)
Infectious disease (2700)
Inflammatory bowel disease (142)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (94)
Interviews (540)
IPO (16129)
IRA (43)
Job creations (3765)
Job search strategy (2075)
Kidney cancer (11)
Labor market (32)
Layoffs (511)
Leadership (21)
Legal (7634)
Liver cancer (69)
Lung cancer (312)
Lymphoma (144)
Machine learning (6)
Management (58)
Manufacturing (298)
MASH (64)
Medical device (13333)
Medtech (13338)
Mergers & acquisitions (19768)
Metabolic disorders (652)
Multiple sclerosis (79)
NASH (15)
Neurodegenerative disease (85)
Neuropsychiatric disorders (29)
Neuroscience (1845)
NextGen: Class of 2025 (6755)
Non-profit (4641)
Northern California (2473)
Now hiring (20)
Obesity (344)
Opinion (240)
Ovarian cancer (69)
Pain (88)
Pancreatic cancer (81)
Parkinson's disease (145)
Partnered (21)
Patents (227)
Patient recruitment (107)
Peanut (50)
People (60824)
Pharmaceutical (25)
Pharmacy benefit managers (18)
Phase I (20369)
Phase II (28747)
Phase III (21395)
Pipeline (1119)
Policy (138)
Postmarket research (2708)
Preclinical (8773)
Press Release (72)
Prostate cancer (101)
Psychedelics (32)
Radiopharmaceuticals (261)
Rare diseases (372)
Real estate (6367)
Recruiting (66)
Regulatory (22129)
Reports (35)
Research institute (2360)
Resumes & cover letters (447)
Rett syndrome (4)
RNA editing (3)
RSV (38)
Schizophrenia (70)
Series A (135)
Series B (88)
Service/supplier (9)
Sickle cell disease (55)
Southern California (2158)
Special edition (14)
Spinal muscular atrophy (151)
Sponsored (32)
Startups (3455)
State (2)
Stomach cancer (11)
Supply chain (66)
Tariffs (22)
The Weekly (43)
United States (21755)
Vaccines (661)
Venture capitalists (36)
Weight loss (223)
Women's health (32)
Worklife (18)
Date
Today (156)
Last 7 days (603)
Last 30 days (2467)
Last 365 days (32208)
2025 (9781)
2024 (34380)
2023 (38965)
2022 (50022)
2021 (54822)
2020 (53595)
2019 (47242)
2018 (36009)
2017 (32669)
2016 (32427)
2015 (38110)
2014 (31516)
2013 (27515)
2012 (29023)
2011 (29518)
2010 (28290)
Location
Africa (909)
Alabama (54)
Alaska (7)
Arizona (198)
Arkansas (14)
Asia (40478)
Australia (7034)
California (5657)
Canada (1908)
China (486)
Colorado (259)
Connecticut (268)
Delaware (136)
Europe (92815)
Florida (855)
Georgia (203)
Idaho (59)
Illinois (539)
India (26)
Indiana (298)
Iowa (8)
Japan (156)
Kansas (97)
Kentucky (23)
Louisiana (10)
Maine (70)
Maryland (861)
Massachusetts (4140)
Michigan (231)
Minnesota (354)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (59)
New Hampshire (60)
New Jersey (1677)
New Mexico (30)
New York (1642)
North Carolina (988)
North Dakota (7)
Northern California (2473)
Ohio (202)
Oklahoma (15)
Oregon (35)
Pennsylvania (1242)
Puerto Rico (11)
Rhode Island (30)
South America (1300)
South Carolina (23)
South Dakota (1)
Southern California (2158)
Tennessee (96)
Texas (863)
Utah (177)
Virginia (141)
Washington D.C. (57)
Washington State (522)
West Virginia (3)
Wisconsin (58)
700,592 Results for "laboratory corporation of america holdings labcorp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide
April 2, 2025
·
3 min read
Press Releases
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
April 24, 2025
·
4 min read
Press Releases
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer’s Disease
April 2, 2025
·
3 min read
Press Releases
Labcorp to Announce First Quarter Financial Results on April 29, 2025
March 31, 2025
·
1 min read
Bio NC
Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
Labcorp, a global leader of innovative and comprehensive laboratory services, announced new strategic service offerings within its precision oncology portfolio.
June 3, 2024
·
2 min read
Bio NC
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials
Labcorp announced today the launch of Labcorp Global Trial Connect, a suite of central laboratory solutions aimed at increasing the speed of clinical trials where the heart of clinical research is conducted – investigator sites.
June 17, 2024
·
2 min read
Press Releases
Labcorp Announces 2024 Fourth Quarter and Full Year Results
February 6, 2025
·
23 min read
Deals
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a transaction to sell certain assets of Enzo’s Clinical laboratory division (Enzo Clinical Labs) to Laboratory Corporation of America Holdings (Labcorp) (NYSE:LH) pursuant to an Asset Purchase Agreement dated March 16, 2023, as amended July 3, 2023.
July 24, 2023
·
3 min read
Business
Labcorp Announces 2024 First Quarter Results
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the first quarter ended March 31, 2024 and updated full-year guidance.
April 25, 2024
·
23 min read
Press Releases
Labcorp Announces Acquisition of Select Assets of BioReference Health’s Innovative Oncology and Related Clinical Testing Services Businesses
March 11, 2025
·
5 min read
1 of 70,060
Next
